Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ
Closed
Oct 7, 2026
Day's Range
19.5352 wk Range
9.56Profile - AMRX - Amneal Pharmaceuticals, Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8.70K
Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company that develops, manufactures, markets, and distributes a broad portfolio of essential medicines. Its current business centers on generics, injectables, biosimilars, and specialty branded pharmaceutical products, serving patients and healthcare providers across the United States and other international markets. The company operates through three main segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment spans a wide range of dosage forms and delivery systems, including oral solids, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, ophthalmics, and transdermal therapies. The Specialty segment focuses on branded treatments for selected therapeutic areas, while AvKARE supplies pharmaceuticals, medical, and surgical products and services to governmental agencies. Headquartered in Bridgewater, New Jersey, Amneal Pharmaceuticals plays a significant role in expanding access to cost-effective and differentiated medicines within the global pharmaceutical market.
Profile Details
Type
Common Stock
Address
400 Crossing Boulevard
City
Bridgewater
State
NJ
Zip
08807
Country
United States
Phone
908 947 3120
Key Executives - AMRX - Amneal Pharmaceuticals, Inc.
Key executives
Cross Listings - AMRX - Amneal Pharmaceuticals, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
